Protara Therapeutics Inc. (TARA), a clinical-stage company developing transformative therapies for cancer and rare diseases, is set to deliver a pivotal presentation on April 26, 2025, at the American Urological Association Annual Meeting, featuring new data from the ongoing ADVANCED-2 trial of TARA-002.
ADVANCED-2 is a phase II trial of investigational cell therapy TARA-002 in adults with high-grade non-muscle invasive bladder cancer.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.